erlotinib hydrochloride has been researched along with zaleplon in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (zaleplon) | Trials (zaleplon) | Recent Studies (post-2010) (zaleplon) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 271 | 44 | 102 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin-Muttitt, K; Goh, EJH; Lau, AJ; Mullins, JGL; Saburulla, NF; Sivanandam, P; Tan, ARY; Tan, WK; Yap, ZP | 1 |
1 other study(ies) available for erlotinib hydrochloride and zaleplon
| Article | Year |
|---|---|
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Topics: Acetamides; Aldehyde Oxidase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erlotinib Hydrochloride; Gefitinib; Humans; Liver; Methotrexate; Molecular Docking Simulation; Protein Conformation; Pyrimidines | 2020 |